Finally, since familial cases of pituitary germline mutations responsible for the pathogenesis of PitNETs have been described, such as those in MEN1 or AIP, and such mutations may be present in a sporadic setting and correlate with tumor aggressiveness since tumors with MEN1 or AIP mutations have been reported to be resistant to conventional treatment [178]. This evidence concerns the gene MEN1 and neoplasm.